Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5322674 | 0.85 | SLC7A5 (0.44) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL2485256 | 0.85 | SLC7A5 (0.44) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL5323152 | 0.76 | SLC1A2 (0.40) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL26277800 | 0.76 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL4902637 | 0.75 | GLO1 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL19525723 | 0.75 | GLO1 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL30626325 | 0.75 | GLO1 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL8982021 | 0.75 | GLO1 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1GLO1 | |
| SCHEMBL27644076 | 0.74 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL10845960 | 0.74 | TDP1 (0.39) | ADRA1ATDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | SLC7A5 3712/4885SLC1A3 4472/4885SLC1A2 4787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.